Global In Vitro Diagnostics/IVD Market – Industry Trends - Forecast to 2026

  • In Vitro Diagnostics
  • Upcoming Report
  • Nov 2018
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global In Vitro Diagnostics/IVD Market By Technology (Immunochemistry/Immunoassays, Clinical Chemistry, Molecular Diagnostics, Clinical Microbiology, Hematology, Coagulation and Hemostasis), By Product & Service (Reagents & Kits, Instruments, Data Management Software, Services), By Application (Diabetes, Infectious Diseases, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing or Pharmacogenomics, HIV/AIDS), By End-User (Hospitals, Laboratories, Point-Of-Care Testing, Patient Self-Testing, Academic Institutes), By Geography  - Industry Trends and Forecast to 2024.

Market Analysis: Global In Vitro Diagnostics/IVD Market

Increasing use of Point-Of-Care Testing has increased the demand for In Vitro Diagnostics/IVD which will see the estimated value of it rise from USD 63.38 billion in 2018 to an estimated value of USD 101.03 billion by 2026, registering a CAGR of 6% in the forecast period of 2019-2026

Market Definition: Global In Vitro Diagnostics/IVD Market

In Vitro Diagnostics are tests that are performed on an individual’s blood/tissue sample. They are used to accurately test and diagnose diseases or any underlying conditions; they also help maintain constant monitoring over the patient’s health. Benefits of these diagnostic tests are that they help identify every individual’s best course of treatment.

Market Drivers:

  • Increasing acceptance and establishment of Point-Of-Care Testing is expected to drive the market growth
  • Growing awareness about the benefits of recognized and personalized medicine for every individual

Market Restraints:

  • Constant upgradation in regulations by the authorities is expected to restrain the market growth
  • Reimbursement of these diagnostic tests is not completely established yet by the insurance companies which is expected to restrain the market growth

Segmentation: Global In Vitro Diagnostics/IVD Market

  • By Product & Service

    • Reagents & Kits
    • Instruments

      • Fully-Automated Instruments
      • Semi-Automated Instruments
      • Others

    • Data Management Software
    • Services

  • By Technology

    • Immunochemistry/Immunoassay

      • Enzyme-Linked Immunosorbent Assay (ELISA)

        • Chemiluminescence Immunoassay (CLIA)
        • Fluorescence Immunoassay (FIA)
        • Colorimetric Immunoassay (CI)

      • Radioimmunoassays (RIA)
      • Rapid Tests
      • Western Blot
      • Enzyme-Linked Immunospot (ELISPOT)

    • Clinical Chemistry

      • Basic Metabolic Panel
      • Electrolyte Panel
      • Liver Panel
      • Lipid Profile
      • Renal Profile
      • Thyroid Function Panel
      • Specialty Chemicals

    • Molecular Diagnostics

      • Polymerase Chain Reaction (PCR)
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Hybridization

        • In-Situ Hybridization
        • Fluorescence In-Situ Hybridization

      • DNA Sequencing & Next-Generation Sequencing (NGS)
      • Microarray
      • Others

    • Microbiology
    • Hematology
    • Coagulation & Hemostasis
    • Urinalysis
    • Others

  • By Application

    • Infectious Diseases
    • Oncology/Cancer
    • Cardiology
    • Nephrology
    • Gastrointestinal Diseases

  • By End-User

    • Laboratories
    • Large/Reference Laboratories
    • Medium-Sized Laboratories
    • Small Laboratories
    • Hospitals
    • Academics
    • Point-Of-Care Testing
    • Patient Self-Testing
    • Others

  • By Geography

    • North America

      • US
      • Canada
      • Mexico

    • South America

      • Brazil
      • Argentina
      • Rest of South America

    • Europe

      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe

    • Asia-Pacific

      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Malaysia
      • Indonesia
      • Thailand
      • Philippines
      • Rest of Asia-Pacific

    • Middle East and Africa

      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East and Africa

Key Developments in the Market:

  • In April 2018, Roche Diagnostics completed a USD 1.9 billion acquisition of Flatiron Health, that will expand the personalized health data of Roche
  • In February 2016, Beckman Coulter Diagnostics released the compact DxH500 hematology system, which would be able to deliver quick and accurate results with just a speck of blood

Competitive Analysis: Global In Vitro Diagnostics/IVD Market 

The global in vitro diagnostics/IVD market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of In Vitro Diagnostics/IVD market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Research Methodology: Global In Vitro Diagnostics/IVD Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Key Market Competitors: Global In Vitro Diagnostics/IVD Market 

Few of the major competitors currently working in the In Vitro Diagnostics/IVD Market are F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Danaher, Abbott, Thermo Fisher Scientific Inc, Johnson & Johnson Services Inc., BD, Bio-Rad Laboratories Inc., Sysmex Corporation, bioMérieux SA, DiaSorin, Ortho Clinical Diagnostics, Agilent Technologies Inc., QIAGEN, Bayer AG, Hologic Inc., Cepheid, Diagnostica Stago S.A.S., Leica Biosystems Nussloch GmbH, Quidel Corporation, OraSure Technologies Inc., Beckman Coulter Inc., and ARKRAY Inc.

Key Insights in the report:

  • The key market players are analyzed and their effects on the market is also observed
  • Market analysis is conducted for the forecast period of 2019 to 2026, and the market segmentations are observed during that period
  • The market drivers and restraints have been clearly analyzed for the effect that they have over the market in the forecast period of 2019 to 2026


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19